Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
淀粉样变性
淀粉样蛋白（真菌学）
作者
Mathew S. Maurer,Jeffrey H. Schwartz,Balarama Gundapaneni,Perry Elliott,Giampaolo Merlini,Márcia Waddington-Cruz,Arnt V. Kristen,Martha Grogan,Ronald Witteles,Thibaud Damy,Brian Drachman,Sanjiv J. Shah,Mazen Hanna,Daniel P. Judge,Alexandra I. Barsdorf,Peter M. Huber,Terrell A. Patterson,Steven Riley,Jennifer Schumacher,Michelle Stewart,Marla B. Sultan,Claudio Rapezzi
Transthyretin amyloid cardiomyopathy is caused by the deposition of transthyretin amyloid fibrils in the myocardium. The deposition occurs when wild-type or variant transthyretin becomes unstable and misfolds. Tafamidis binds to transthyretin, preventing tetramer dissociation and amyloidogenesis.
井哥儿
干净的铅笔
1257
我不爱池鱼
爱静静
热切菩萨
梦之凌云
从容芮
InfoNinja
stuffmatter
pcr163
不懈奋进
Yziii
HEIKU
薰硝壤
张三坟
哎嘿
pluto
Leonardi
可言飞舞
皖公网安备34019202002308
